Constitutional Authority Statement for H.R. 6190; Congressional Record Vol. 158, No. 112
(House of Representatives - July 25, 2012)

Text available as:

Formatting necessary for an accurate reading of this text may be shown by tags (e.g., <DELETED> or <BOLD>) or may be missing from this TXT display. For complete and accurate display of this text, see the PDF.

[Page H5292]
From the Congressional Record Online through the Government Publishing Office []

           By Mr. BURGESS:
       H.R. 6190.
       Congress has the power to enact this legislation pursuant 
     to the following:
       The attached legislation falls within Congress' authority 
     to regulate interstate commerce as found in Article I, 
     Section 8, clause 3 of the U.S. Constitution, which provides 
     the authority for the Congress to ``To regulate Commerce with 
     foreign Nations, and among the several States, and with the 
     Indian Tribes.'' The epinephrine inhalers at issue in the 
     attached legislation are regulated by the federal Food and 
     Drug Administration (FDA), and the propellant at issue is 
     regulated by the Environmental Protection Agency. The product 
     further falls within the subject matter of an international 
     treaty known as the Montreal Protocol on Substances that 
     Deplete the Ozone Layer, of which the U.S. is a signatory.